BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18337555)

  • 1. Association between the proliferative rate of neoplastic B cells, their maturation stage, and underlying cytogenetic abnormalities in B-cell chronic lymphoproliferative disorders: analysis of a series of 432 patients.
    Quijano S; López A; Rasillo A; Barrena S; Luz Sánchez M; Flores J; Fernández C; Sayagués JM; Osuna CS; Fernández N; González M; Giraldo P; Giralt M; Pérez MC; Martin-Antoran JM; Gutiérrez O; Perdiguer L; Díaz Mediavilla J; González Silva M; Asensio Del Rio A; Cerveró C; Guerra JL; Butrón R; García Mdel C; Almeida J; Orfao A
    Blood; 2008 May; 111(10):5130-41. PubMed ID: 18337555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD5-positive chronic B-cell lymphoproliferative disorders: diagnosis and prognosis of a heterogeneous disease entity.
    Dronca RS; Jevremovic D; Hanson CA; Rabe KG; Shanafelt TD; Morice WG; Call TG; Kay NE; Collins CS; Schwager SM; Slager SL; Zent CS
    Cytometry B Clin Cytom; 2010; 78 Suppl 1(Suppl 1):S35-41. PubMed ID: 20568273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subtype Distribution, Clinical Features, and Survival in B-cell Chronic Lymphoproliferative Disorders in China: A Review of 1592 Cases.
    Yan Y; Lv R; Xiong W; Li Z; Wang Y; Yu Y; Yu Z; Wang T; Sui W; Liu W; Zou D; Yi S; Qiu L
    Clin Lymphoma Myeloma Leuk; 2020 Jun; 20(6):e270-e283. PubMed ID: 32220598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden.
    Kristinsson SY; Björkholm M; Goldin LR; McMaster ML; Turesson I; Landgren O
    Blood; 2008 Oct; 112(8):3052-6. PubMed ID: 18703425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Research Progress on Diagnosis and Treatment of B Cell Chronic Lymphoproliferative Disease--Review].
    Li YY; Hu DZ; Tian C
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Aug; 26(4):1220-1224. PubMed ID: 30111434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectrum and immunophenotyping of 653 patients with B-cell chronic lymphoproliferative disorders in China: A single-centre analysis.
    Miao Y; Cao L; Sun Q; Li XT; Wang Y; Qiao C; Wang L; Wang R; Qiu HR; Xu W; Li JY; Wu YJ; Fan L
    Hematol Oncol; 2018 Feb; 36(1):121-127. PubMed ID: 28752619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic value of CD1d expression in a large cohort of patients with B-cell chronic lymphoproliferative disorders.
    Kotsianidis I; Nakou E; Spanoudakis E; Bouchliou I; Moustakidis E; Miltiades P; Vadikolia CM; Szydlo R; Karadimitris A; Tsatalas C
    Am J Clin Pathol; 2011 Sep; 136(3):400-8. PubMed ID: 21846915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical Features and Outcomes of the Patients with B-Cell Chronic Lymphoproliferative Disease in the New Drug Era].
    Xu CB; Hu M; Shen JZ; Xu HQ; Zheng RJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):722-729. PubMed ID: 37356932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD5-Negative, CD10-Negative Low-Grade B-Cell Lymphoproliferative Disorders of the Spleen.
    Schmieg JJ; Muir JM; Aguilera NS; Auerbach A
    Curr Oncol; 2021 Dec; 28(6):5124-5147. PubMed ID: 34940069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of chromosomal rearrangements in bone marrow cells and blast transformed B-cells in relapse of B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Andreieva SV; Korets KV; Ruzhinska OE; Skorokhod IM; Alkhimova OG
    Exp Oncol; 2017 Jul; 39(2):141-144. PubMed ID: 29483496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Identification of splenic marginal zone lymphoma from B lymphoproliferative disorders by flow cytometry].
    Hu Y; Chen Y; Wang LH; Chen X; Fang F; Liu SQ; Wu XQ; Zhu P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):349-56. PubMed ID: 24763004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Primary ocular adnexal lymphoproliferative lesions: clinicopathologic features and genetic alterations].
    Dong LN; Liu HG; Jin HS; Ye HT; Gao ZF; Zhou XG; Dong GH; Zhang DD; Gong LP
    Zhonghua Bing Li Xue Za Zhi; 2008 Dec; 37(12):809-14. PubMed ID: 19159526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic abnormalities in chronic B-cell lymphoproliferative disorders in Chinese patients.
    Wong KF; Chan JK
    Cancer Genet Cytogenet; 1999 May; 111(1):55-60. PubMed ID: 10326592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adhesion molecules in B-chronic lymphoproliferative disorders.
    Angelopoulou MK; Kontopidou FN; Pangalis GA
    Semin Hematol; 1999 Apr; 36(2):178-97. PubMed ID: 10319387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetic and molecular cytogenetic profile of bone marrow-derived mesenchymal stromal cells in chronic and acute lymphoproliferative disorders.
    Campioni D; Bardi MA; Cavazzini F; Tammiso E; Pezzolo E; Pregnolato E; Volta E; Cuneo A; Lanza F
    Ann Hematol; 2012 Oct; 91(10):1563-77. PubMed ID: 22696050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular lesions in B-cell lymphoproliferative disorders: recent contributions from studies utilizing high-throughput sequencing techniques.
    Blombery PA; Dickinson M; Westerman DA
    Leuk Lymphoma; 2014 Jan; 55(1):19-30. PubMed ID: 23550993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD200 Expression in Diagnostic and Prognostic Assessment of Mature B Cell Lymphophoproliferative Neoplasms.
    El Din Fouad NB; Ibrahim NY; Abdel Aziz RS; Ibrahim SK
    Asian Pac J Cancer Prev; 2018 Dec; 19(12):3383-3392. PubMed ID: 30583344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.
    Quijano S; López A; Rasillo A; Sayagués JM; Barrena S; Sánchez ML; Teodosio C; Giraldo P; Giralt M; Pérez MC; Romero M; Perdiguer L; Orfao A
    Cytometry B Clin Cytom; 2008 May; 74(3):139-49. PubMed ID: 18061951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MYD88 L265P somatic mutation: its usefulness in the differential diagnosis of bone marrow involvement by B-cell lymphoproliferative disorders.
    Ondrejka SL; Lin JJ; Warden DW; Durkin L; Cook JR; Hsi ED
    Am J Clin Pathol; 2013 Sep; 140(3):387-94. PubMed ID: 23955458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.